📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis. (2021)

First Author: Zifodya JS

Attributed to: E Ochodo, Stellenbosch University, Evidence synthesis for building a translation pipeline to eliminate infectious diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/14651858.cd009593.pub5

PubMed Identifier: 33616229

Publication URI: http://europepmc.org/abstract/MED/33616229

Type: Journal Article/Review

Volume: 2

Parent Publication: The Cochrane database of systematic reviews

ISSN: 1361-6137